<DOC>
	<DOCNO>NCT01980732</DOCNO>
	<brief_summary>The primary objective study evaluate 68Ga-DOTA TATE PET/CT stag monitoring response chemotherapy patient carcinoid , neuroendocrine tumor , medullary thyroid cancer cancer express somatostatin receptor .</brief_summary>
	<brief_title>68Ga DOTA-TATE PET/CT Somatostatin Receptor Positive Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>Greater 18 yearsold time radiotracer administration Provides write informed consent Known diagnosis NET suspect SSTR positive tumor 111InOctreotide scan , 18FDGPET , MRI abdomen clinically indicate Karnofsky score great 50 ECOG Performance Status 02 Women childbearing age must negative pregnancy test screening/baseline Able remain still duration image procedure ( one hour ) Less 18 yearsold time radiotracer administration Pregnant nursing Serum creatinine &gt; 3.0 mg/dL Hepatic enzyme level 5 time upper limit normal . Use investigational product device within 30 day prior dose , know requirement investigational agent prior completion schedule study assessment . Inability lie still entire imaging time Inability complete need investigational standardofcare image examination due reason ( severe claustrophobia , radiation phobia , etc . ) Any additional medical condition , serious intercurrent illness , extenuate circumstance , opinion Investigator , may significantly interfere study compliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>